Vaccine to treat and prevent prostate cancer

Summary:

A Spanish research institution has developed an immunotherapy approach based on a bifunctional compound for the treatment and prevention of prostate cancer, the second most common cancer worldwide for men and the fifth most common cancer overall.

Industrial partners from the pharmaceutical industry are being sought, for collaboration through a patent licence agreement.

Reference: TOES20200323001

Country: Spain

Submitted: 8. 5. 2020

View Partnering Opportunity

Keywords

Technology: Pharmaceutics; Human vaccines; Pharmaceutical Products / Drugs

Market: Oncology; Pharmaceuticals/fine chemicals

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.